Literature DB >> 22179975

Detection of PAX8-PPARG fusion transcripts in archival thyroid carcinoma samples by conventional RT-PCR.

Markus Klemke1, Norbert Drieschner, Gazanfer Belge, Käte Burchardt, Klaus Junker, Jörn Bullerdiek.   

Abstract

The t(2;3)(q13;p25) occurs in a subgroup of follicular-patterned thyroid tumors and leads to a fusion of the genes encoding for the thyroid-specific transcription factor paired box 8 (PAX8) and the peroxisome proliferator-activated receptor gamma (PPARγ). Although initially discovered in follicular carcinomas (FTC), the fusion transcripts were also detected in a small fraction of follicular adenomas and rarely in follicular variants of papillary carcinomas (FV-PTC). In most RT-PCR based studies, fresh or snap-frozen tissue samples were used. The aim of the present study was to develop a method for the detection of chimeric PAX8-PPARG transcripts in formalin-fixed paraffin-embedded (FFPE) thyroid tumor samples by conventional RT-PCR. For this purpose, RNA from FFPE samples of 21 FTC, seven FV-PTC, and one bone metastasis derived from an FTC was subjected to RT-PCR with subsequent gel electrophoretic separation of the products. Fusion transcripts were detected in 2/21 primary FTC (9.5%) and in the bone metastasis, but they were undetectable in all seven FV-PTC under investigation. The RT-PCR approach described herein allows to detect all known variants of PAX8-PPARG fusion transcripts and is applicable to FFPE tissues. Thus, it can be used to screen archival thyroid tumor samples for the gene fusion.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22179975     DOI: 10.1002/gcc.21925

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  5 in total

1.  Genetic Alterations in Hungarian Patients with Papillary Thyroid Cancer.

Authors:  Bálint Tobiás; Csaba Halászlaki; Bernadett Balla; János P Kósa; Kristóf Árvai; Péter Horváth; István Takács; Zsolt Nagy; Evelin Horváth; János Horányi; Balázs Járay; Eszter Székely; Tamás Székely; Gabriella Győri; Zsuzsanna Putz; Magdolna Dank; Zsuzsanna Valkusz; Béla Vasas; Béla Iványi; Péter Lakatos
Journal:  Pathol Oncol Res       Date:  2015-08-11       Impact factor: 3.201

2.  Detection of Hepatitis B Virus M204I Mutation by Quantum Dot-Labeled DNA Probe.

Authors:  Cheng Zhang; Yiping Chen; Xinmiao Liang; Guanhua Zhang; Hong Ma; Leng Nie; Yu Wang
Journal:  Sensors (Basel)       Date:  2017-04-26       Impact factor: 3.576

3.  Activation of the two microRNA clusters C19MC and miR-371-3 does not play prominent role in thyroid cancer.

Authors:  Volkhard Rippe; Inga Flor; Johannes Wolfram Debler; Norbert Drieschner; Birgit Rommel; Daniel Krause; Klaus Junker; Jörn Bullerdiek
Journal:  Mol Cytogenet       Date:  2012-10-15       Impact factor: 2.009

4.  Correlated expression of HMGA2 and PLAG1 in thyroid tumors, uterine leiomyomas and experimental models.

Authors:  Markus Klemke; Marietta Henrike Müller; Werner Wosniok; Dominique Nadine Markowski; Rolf Nimzyk; Burkhard Maria Helmke; Jörn Bullerdiek
Journal:  PLoS One       Date:  2014-02-07       Impact factor: 3.240

5.  Polymorphism in lncRNA AC016683.6 and its interaction with smoking exposure on the susceptibility of lung cancer.

Authors:  Juan Li; Hang Li; Xiaoting Lv; Zitai Yang; Min Gao; Yanhong Bi; Ziwei Zhang; Shengli Wang; Zhigang Cui; Baosen Zhou; Zhihua Yin
Journal:  Cancer Cell Int       Date:  2018-07-04       Impact factor: 5.722

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.